Author: Alkemata Workshop

Five evidence-led developments: alcohol screening, a coeliac trial, Amazon fire smoke, the EU methane proposal and atom-thin transistors.

Four evidence-led developments: Ebola crosses a new threshold, an mRNA cancer trial misses one endpoint, hurricane recovery exposes cascading infrastructure, and dry electrodes work for 14 days without retraining.

Four developments worth attention: faster outbreak detection, cyber-risk in food infrastructure, financial exposure to the AI boom, and a hard test for Europe’s Mars rover.

Four evidence-led developments on partial sight restoration, deceptive safety controls, climate accountability and open biological data for predictive models.

A global pain benchmark, hard lessons from the Ebola response, an EU methane-rule delay, and a privately financed nuclear expansion for the PJM grid.

Four evidence-led developments on a child-sized heart valve, EU online safety, retail crypto oversight and accountable cybersecurity.

Four developments on obesity treatment, algorithmic rent setting, data-centre grid costs and the limits of fair use in AI training.

Four evidence-led developments: longer-term Huntington’s gene-therapy data, deadly Asian floods, Google’s EU privacy-and-competition appeal, and Starship’s mixed orbital test.